Marksans Pharma

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue741.98774.57891.28866.20958.32
Expenses608.65623.95691.29659.63764.82
EBITDA166.07180.89230.60238.44232.44
EBIT139.15156.56206.31213.57200.33
Profit Before Tax133.34150.62200.00206.57193.51
Net Profit99.14113.69149.03159.41143.53
Financial Ratios
Operating Profit Margin23.05%23.98%26.94%28.36%24.72%
Net Profit Margin13.64%15.00%17.30%18.69%15.03%
Earning Per Share (Diluted)2.172.503.273.473.11
Dividends Per Share0.000.000.000.000.00